dobutamine has been researched along with Disease Exacerbation in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (20.00) | 18.2507 |
| 2000's | 11 (36.67) | 29.6817 |
| 2010's | 11 (36.67) | 24.3611 |
| 2020's | 2 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; Kelly, J; Lupi, K; Malloy, R | 1 |
| Chen, X; Lei, J; Liao, X; Qian, L; Zhang, S | 1 |
| Hall, ME; Hamilton, C; Hundley, WG; Jordan, JH; Kitzman, DW; Morgan, TM; Stacey, RB; Vasu, S; Vera, T; Whitlock, MC | 1 |
| Bacaksiz, A; Erdogan, E; Ergelen, M; Erturk, M; Karakurt, H; Sonmez, O; Tasal, A; Turfan, M; Uyarel, H; Vatankulu, MA | 1 |
| Bendtsen, F; Dahl, EK; Kjær, A; Krag, A; Møller, S; Petersen, CL | 1 |
| Hautamäki, R; Hovilehto, S; Inkinen, O; Karlsson, S; Kaukonen, KM; Korhonen, AM; Kuitunen, A; Laru-Sompa, R; Pettilä, V; Poukkanen, M; Uusaro, A; Vaara, ST; Wilkman, E | 1 |
| Buonincontri, G; Carpenter, TA; Morton, AJ; Puttick, SG; Sawiak, SJ; Ward, AO; Wood, NI | 1 |
| Balestra, GM; Eerbeek, O; Mik, EG; Specht, PA; van der Laarse, WJ; Zuurbier, CJ | 1 |
| Boiten, HJ; Roest, S; Schinkel, AFL; Valkema, R; van Domburg, RT | 1 |
| Frick, M; Furundzija, V; Gebker, R; Jahnke, C; Manka, R; Marx, N; Paetsch, I; Schnackenburg, B | 1 |
| Fleck, E; Gebker, R; Hucko, T; Jahnke, C; Kelle, S; Klein, C; Manka, R; Paetsch, I; Schnackenburg, B | 1 |
| Burger, AJ; Josephson, ME; Mittleman, MA; Nearing, BD; Verrier, RL; Wellenius, GA | 1 |
| Camelliti, P; Carr, CA; Clarke, K; Davies, KE; Stuckey, DJ; Tyler, DJ | 1 |
| Adams, KF; Gattis, WA; Gheorghiade, M; Jaffe, AS; O'Connor, CM | 1 |
| Buttrick, PM; Geenen, DL; Goldspink, PH; McKinney, RD; Montgomery, DE; Solaro, RJ; Urboniene, D; Walker, LA | 1 |
| Badagliacca, R; Fedele, F; Sciomer, S; Vizza, CD | 1 |
| Ducharme, A; Guertin, MC; He, Y; Ibrahim, R; Lavoie, J; Racine, N; Rouleau, JL; Schiffrin, EL; Touyz, RM; White, M; Whittom, L; Yao, G | 1 |
| Bax, JJ; Biagini, E; Boersma, E; Crea, F; Elhendy, A; Maat, A; Palazzuoli, A; Poldermans, D; Rizzello, V; Schinkel, AF; Sozzi, FB | 1 |
| Barber, BJ; Benson, DW; Cripe, LH; Markham, LW; Spicer, RL; Weidner, N; Wong, BL | 1 |
| Du, J; Feng, HZ; Gobara, N; Hossain, MM; Huang, XP; Jean-Charles, PY; Jin, JP; Li, Y; Liu, J; Zhang, C | 1 |
| Berger, R; Daneschvar, H; Frey, B; Grimm, M; Hülsmann, M; Laufer, G; Pacher, R; Rödler, S; Siegel, A; Stanek, B | 1 |
| Cribier, A; Derumeaux, G; Letac, B; Redonnet, M; Soyer, R | 1 |
| Braun, W; Lauer, MS; Lobo, A; Marwick, TH; Nally, J | 1 |
| Berger, R; Bojic, A; Frey, B; Grimm, M; Hülsmann, M; Laufer, G; Locker, G; Pacher, R; Rödler, S; Stanek, B; Sturm, B | 1 |
| Sen, S | 1 |
| Angermann, CE; Henneke, KH; Klauss, V; Mudra, H; Reichart, B; Rieber, J; Schnaack, SD; Siebert, U; Spes, CH; Tammen, AR; Theisen, K; Uberfuhr, P | 1 |
| Lagioia, R; Napoli, V; Passantino, A; Ricci, A; Rizzon, P; Scrutinio, D | 1 |
| Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF | 1 |
| Asano, H; Chen, CH; Kobayashi, J; Kobayashi, T; Kyo, S; Masutani, S; Sasaki, N; Senzaki, H; Taketazu, M; Yokote, Y | 1 |
| Fisher, NG; Kaul, S; Le, DE; Leong-Poi, H; Rim, SJ; Wei, K | 1 |
2 review(s) available for dobutamine and Disease Exacerbation
| Article | Year |
|---|---|
Network Meta-Analysis of the Safety of Drug Therapy for Cardiogenic Shock.
Topics: Aged; Disease Progression; Dobutamine; Dopamine; Epinephrine; Female; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Natriuretic Peptide, Brain; Network Meta-Analysis; Norepinephrine; Patient Safety; Recombinant Proteins; Shock, Cardiogenic; Simendan; Treatment Outcome | 2020 |
[Echocardiography in aortic stenosis: new insights into challenging scenarios].
Topics: Aged; Aortic Valve Stenosis; Cardiotonic Agents; Clinical Trials as Topic; Death, Sudden, Cardiac; Diagnosis, Differential; Disease Progression; Dobutamine; Echocardiography; Heart Failure; Heart Valve Prosthesis Implantation; Hemodynamics; Humans; Myocardial Contraction; Prognosis; Risk Factors; Severity of Illness Index; Time Factors; Ventricular Dysfunction, Left | 2004 |
5 trial(s) available for dobutamine and Disease Exacerbation
| Article | Year |
|---|---|
Diastolic and autonomic dysfunction in early cirrhosis: a dobutamine stress study.
Topics: Adolescent; Adult; Aged; Atrial Natriuretic Factor; Atropine; Autonomic Nervous System; Biomarkers; Blood Pressure; Cardiac Output; Case-Control Studies; Disease Progression; Dobutamine; Electrocardiography; Female; Heart; Heart Rate; Humans; Liver Cirrhosis; Male; Middle Aged; Myocardial Contraction; Parasympatholytics; Severity of Illness Index; Stress, Physiological; Sympathomimetics; Young Adult | 2014 |
Crescendo in depolarization and repolarization heterogeneity heralds development of ventricular tachycardia in hospitalized patients with decompensated heart failure.
Topics: Cardiotonic Agents; Disease Progression; Dobutamine; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Prognosis; Prospective Studies; Tachycardia, Ventricular | 2012 |
Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
Topics: Cardiotonic Agents; Disease Progression; Dobutamine; Double-Blind Method; Endpoint Determination; Heart Failure; Hospitalization; Humans; Multicenter Studies as Topic; Natriuretic Agents; Natriuretic Peptide, Brain; Patient Selection; Pilot Projects; Randomized Controlled Trials as Topic; Troponin I; Troponin T | 2003 |
Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
Topics: Biomarkers; C-Reactive Protein; Cardiotonic Agents; Case-Control Studies; Cell Adhesion Molecules; Chemokine CCL2; Colorimetry; Cytokines; Dinoprost; Disease Progression; Dobutamine; E-Selectin; Enzyme-Linked Immunosorbent Assay; Exercise Test; Female; Heart Failure; Humans; Inflammation; Interleukin-18; Interleukin-6; Male; Middle Aged; Milrinone; Oxidative Stress; Thiobarbituric Acid Reactive Substances; Tyrosine | 2006 |
Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine.
Topics: Alprostadil; Ambulatory Care; Antihypertensive Agents; Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Cause of Death; Disease Progression; Dobutamine; Epoprostenol; Female; Heart Failure; Heart Transplantation; Hospitalization; Humans; Infusions, Intravenous; Lung; Male; Middle Aged; Pilot Projects; Prospective Studies; Pulmonary Wedge Pressure; Risk Factors; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 1999 |
23 other study(ies) available for dobutamine and Disease Exacerbation
| Article | Year |
|---|---|
Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.
Topics: Aged; Cardiotonic Agents; Cause of Death; Disease Progression; Dobutamine; Female; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Milrinone; Recovery of Function; Retrospective Studies; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2020 |
Asymptomatic myocardial ischemia forecasts adverse events in cardiovascular magnetic resonance dobutamine stress testing of high-risk middle-aged and elderly individuals.
Topics: Adrenergic beta-1 Receptor Agonists; Age Factors; Aged; Aged, 80 and over; Asymptomatic Diseases; Disease Progression; Dobutamine; Female; Hospitalization; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Time Factors | 2018 |
Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Cardiotonic Agents; Disease Progression; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Hydrazones; Infusions, Intravenous; Leukocyte Count; Lymphocyte Count; Male; Middle Aged; Neutrophils; Predictive Value of Tests; Pyridazines; Retrospective Studies; Simendan | 2014 |
Hemodynamic variables and progression of acute kidney injury in critically ill patients with severe sepsis: data from the prospective observational FINNAKI study.
Topics: Acute Kidney Injury; Blood Pressure; Disease Progression; Dobutamine; Furosemide; Hemodynamics; Humans; Hydrogen-Ion Concentration; Intensive Care Units; Lactic Acid; Norepinephrine; Prospective Studies; Sepsis; Vasoconstrictor Agents | 2013 |
Right ventricular dysfunction in the R6/2 transgenic mouse model of Huntington's disease is unmasked by dobutamine.
Topics: Animals; Cardiac Imaging Techniques; Disease Models, Animal; Disease Progression; Dobutamine; Huntington Disease; Longitudinal Studies; Magnetic Resonance Imaging, Cine; Mice; Mice, Transgenic; Stroke Volume; Sympathomimetics; Ventricular Dysfunction, Right | 2014 |
Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
Topics: Administration, Inhalation; Animals; Arterial Pressure; Cardiotonic Agents; Disease Models, Animal; Disease Progression; Dobutamine; Energy Metabolism; Heart Failure; Hexokinase; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; L-Lactate Dehydrogenase; Male; Mitochondria, Heart; Monocrotaline; Oxygen; Oxygen Consumption; Protoporphyrins; Pulmonary Artery; Rats, Wistar; Ventricular Dysfunction, Right; Ventricular Function, Right | 2015 |
Prediction of 14-year cardiovascular outcomes by dobutamine stress
Topics: Aged; Aged, 80 and over; Coronary Artery Disease; Disease Progression; Dobutamine; Exercise Test; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Myocardial Infarction; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2018 |
Gender-based prognostic value of pharmacological cardiac magnetic resonance stress testing: head-to-head comparison of adenosine perfusion and dobutamine wall motion imaging.
Topics: Adenosine; Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Coronary Artery Disease; Coronary Circulation; Disease Progression; Disease-Free Survival; Dobutamine; Female; Germany; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Multivariate Analysis; Myocardial Contraction; Myocardial Infarction; Myocardial Perfusion Imaging; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Sex Factors; Time Factors | 2012 |
The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease.
Topics: Aged; Cardiotonic Agents; Cardiovascular Agents; Chi-Square Distribution; Coronary Angiography; Coronary Artery Disease; Disease Progression; Disease-Free Survival; Dobutamine; Female; Germany; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Patient Selection; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Risk Factors; Time Factors | 2011 |
In vivo MRI characterization of progressive cardiac dysfunction in the mdx mouse model of muscular dystrophy.
Topics: Animals; Disease Models, Animal; Disease Progression; Dobutamine; Fibrosis; Gadolinium; Heart; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred mdx; Muscular Dystrophies; Myocardium; Stress, Physiological; Time Factors; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right | 2012 |
Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure.
Topics: Actin Cytoskeleton; Animals; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Disease Progression; Dobutamine; Drug Resistance; Enzyme Induction; Heart Failure; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Myosin Heavy Chains; Myosin Light Chains; Osteopontin; Phosphorylation; Protein Kinase C; Protein Kinase C-epsilon; Protein Processing, Post-Translational; Recombinant Fusion Proteins; RNA, Messenger; Sialoglycoproteins | 2004 |
Outcome after redo coronary artery bypass grafting in patients with ischaemic cardiomyopathy and viable myocardium.
Topics: Aged; Cardiotonic Agents; Chi-Square Distribution; Coronary Artery Bypass; Disease Progression; Dobutamine; Echocardiography, Stress; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Proportional Hazards Models; Prospective Studies; Recurrence; Reoperation; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2007 |
Outpatient continuous inotrope infusion as an adjunct to heart failure therapy in Duchenne muscular dystrophy.
Topics: Adolescent; Cardiac Output, Low; Cardiotonic Agents; Disease Progression; Dobutamine; Dose-Response Relationship, Drug; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Milrinone; Muscular Dystrophy, Duchenne; Palliative Care; Quality of Life; Time Factors | 2006 |
Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI.
Topics: Age Factors; Animals; Cardiac Output; Cardiomyopathy, Restrictive; Cardiotonic Agents; Cell Size; Diastole; Disease Progression; Dobutamine; Echocardiography, Doppler; Genotype; Heart Failure; Heart Rate; Mice; Mice, Transgenic; Mutation; Myocardial Contraction; Phenotype; Troponin I | 2008 |
Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.
Topics: Alprostadil; Cardiotonic Agents; Catheters, Indwelling; Chronic Disease; Disease Progression; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Safety; Treatment Outcome; Vasodilator Agents | 1997 |
Assessment of the progression of cardiac allograft vasculopathy by dobutamine stress echocardiography.
Topics: Cardiotonic Agents; Coronary Angiography; Coronary Disease; Disease Progression; Dobutamine; Echocardiography; Female; Follow-Up Studies; Heart Transplantation; Humans; Male; Middle Aged; Postoperative Complications; Transplantation, Homologous | 1998 |
Use of dobutamine echocardiography for cardiac risk stratification of patients with chronic renal failure.
Topics: Adrenergic beta-Agonists; Aged; Anti-Arrhythmia Agents; Atropine; Coronary Disease; Death, Sudden, Cardiac; Disease Progression; Disease-Free Survival; Dobutamine; Echocardiography; Female; Humans; Kidney Failure, Chronic; Male; Mass Screening; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Prognosis; Risk | 1998 |
Myocardial response to stress in cardiac hypertrophy and heart failure: effect of antihypertensive drugs.
Topics: Animals; Antihypertensive Agents; Cardiac Output, Low; Cardiomegaly; Cardiotonic Agents; Collagen; Disease Progression; Dobutamine; Heart; Male; Myocardium; Myosins; Protein Isoforms; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Stress, Mechanical | 1999 |
Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound.
Topics: Adrenergic beta-Agonists; Adult; Confounding Factors, Epidemiologic; Coronary Angiography; Coronary Disease; Disease Progression; Dobutamine; Echocardiography; Female; Heart Transplantation; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Risk; Transplantation, Homologous; Ultrasonography, Interventional | 1999 |
Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
Topics: Adrenergic beta-Agonists; Aged; Cardiomyopathy, Dilated; Disease Progression; Dobutamine; Exercise Test; Exercise Tolerance; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Oxygen Consumption; Prognosis; Reproducibility of Results | 2000 |
How many patients with ischemic cardiomyopathy exhibit viable myocardium?
Topics: Aged; Comorbidity; Disease Progression; Dobutamine; Echocardiography, Doppler; Exercise Test; Female; Heart Failure; Heart Function Tests; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Prevalence; Prognosis; Prospective Studies; Risk Factors; Severity of Illness Index; Stroke Volume; Ventricular Dysfunction, Left | 2001 |
Assessment of cardiovascular dynamics by pressure-area relations in pediatric patients with congenital heart disease.
Topics: Adolescent; Age Factors; Body Surface Area; Cardiotonic Agents; Case-Control Studies; Child; Child, Preschool; Data Interpretation, Statistical; Disease Progression; Dobutamine; Echocardiography, Transesophageal; Feasibility Studies; Heart Defects, Congenital; Hemodynamics; Humans; Image Processing, Computer-Assisted; Infant; Severity of Illness Index; Stroke Volume; Ventricular Pressure | 2001 |
Perfusion versus function: the ischemic cascade in demand ischemia: implications of single-vessel versus multivessel stenosis.
Topics: Animals; Cardiotonic Agents; Coronary Circulation; Coronary Stenosis; Disease Models, Animal; Disease Progression; Dobutamine; Dogs; Dose-Response Relationship, Drug; Heart; Hemodynamics; Severity of Illness Index | 2002 |